Semaglutide trial blood samples and a small tirzepatide substudy both showed slower or reversed movement on molecular aging clocks, but the data are unreviewed and the clocks are not proof of longer life.
The FDA's veterinary center accepted the effectiveness section for LOY-003, Loyal's daily pill for big dogs. Safety and manufacturing reviews, and any proof of longer life, still lie ahead.
